Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ubiquitin proteasome system (UPS) is the principal pathway for targeted protein degradation in eukaryotic cells. It is essential for maintaining cellular protein homeostasis by selectively degrading misfolded, damaged, or regulatory proteins that control various cellular processes. The UPS involves ubiquitin, E1, E2, and E3 enzymes, polyubiquitin chains, and the 26S proteasome complex, which consists of the 20S core and two 19S regulators. Dysregulation of the UPS is implicated in various diseases, making it a therapeutic target.
Pharmacological inhibition or modulation of UPS components
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin Proteasome System (UPS).